Description | The formulation is from the literature DOI: 10.1016/j.cej.2024.148769. Collagen II targeting peptide (WYRGRL) is modified on the surface of LNPs, which can be used to target LNPs to chondrocytes in the inflammatory environment, addressing the problem of untargeted treatment of osteoarthritis of the TMJ. |
Lipid composition | DOTAP/Cholesterol/DSPC/DSPE-PEG2000 (50:38.5:10:1.5, mole ratio) |
Product Name | Catalog | Lipid composition | Liposome Size | Price |
---|---|---|---|---|
FA-Lipid Nanoparticles (Targeted to Macrophages) | CDCLP24-001-L | DOTAP/Cholesterol/DSPC/DSPE-PEG2000 (50:38.5:10:1.5, mole ratio) | INQUIRY | |
FPD-Lipid Nanoparticles | CDCLP24-003-L | SM-102/DSPC/cholesterol/FPD (50:10:38.5:1.5, mole ratio) | INQUIRY | |
DB-Lipid Nanoparticles | CDCLP24-004-L | DB-lipidoids(11-10-8)/DOPE/Cholesterol/DMG-PEG (40:10:48.8:1.5, mole ratio) | INQUIRY | |
4N4T-Lipid Nanoparticles | CDCLP24-005-L | 4N4T lipids/DOPE/Chol/DMG-PEG2K (35:16:46.5:2.5, mole ratio) | INQUIRY | |
C5-Lipid Nanoparticles (Targeted to Placenta) | CDCLP24-006-L | C12-494/DOPE/Chol/Lipid-PEG2K (51.4:14:32.7:1.9, mole ratio) | INQUIRY | |
Sito-Lipid Nanoparticles | CDCLP24-007-L | DLin-MC3-DMA/β-sitosterol/DMG-PEG2K/DSPC (50:36.5:3.5:10, mole ratio) | INQUIRY | |
C10-Lipid Nanoparticles (Targeted to Liver) | CDCLP24-008-L | Ionizable lipid/DOPE/Cholesterol/PEG-lipid (26.5:20:52:1.5, mole ratio) | INQUIRY | |
Temperature responsive-Lipid Nanoparticles #1 | CDCLP24-009-L | DPPC:MSPC:DSPE-PEG2000 (86.5:9.7:3.8, mol %) | INQUIRY |